光敏剂
光动力疗法
单线态氧
纳米医学
化学
癌症研究
药品
药理学
医学
纳米技术
材料科学
光化学
纳米颗粒
有机化学
氧气
作者
Guocan Yu,Ben‐Yue Zhu,Li Shao,Jiong Zhou,Manik Lal Saha,Bingbing Shi,Zibin Zhang,Tao Hong,Shijun Li,Xiaoyuan Chen,Peter J. Stang
标识
DOI:10.1073/pnas.1902029116
摘要
Significance The combination of chemotherapy and photodynamic therapy opens up a promising way of overcoming drug resistance, incorporating different mechanisms of actions to achieve synergistic efficacy. However, the antitumor outcome of photodynamic therapy is greatly limited due to the unsatisfactory singlet oxygen generation caused by severe aggregation of the photosensitizer. To this end, we utilize a discrete metallacage containing therapeutic organoplatinum(II) to encapsulate a photosensitizer by forming an inclusion host–guest complex, facilitating the codelivery of chemotherapeutic agent and photosensitizer through nanoformulation. Benefiting from the enhanced permeability and retention effect and active targeting, the nanomedicine exhibits satisfactory antitumor performance against drug-resistant tumor. This pioneering work provides a distinct supramolecular methodology to prepare theranostic systems for multimodality imaging and therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI